NEWSNATIONNOW (Zach Kaplan) - Epinephrine injection recalled over potentially fatal health risks: FDA
Consumers, retailers and health care facilities should stop using the product and discard or return it, the FDA said.
Consumers, retailers and health care facilities should stop using the product and discard or return it, the FDA said.
Patients taking the affected lot are advised not to discontinue use without first consulting their health care provider.
The FDA allowed some Zyn nicotine pouches to be marketed as "lower risk" than cigarettes. Public health experts agree they can help current smokers, but worry young people may become addicted.
The FDA reports state the recalls affect more than 944,000 bottles of the medications.
A nationwide recall has been issued for multiple drugs used in hospital settings after they failed to meet Food and Drug Administration safety standards.
The recall is classified as Class III, the FDA’s lowest risk level, meaning it's "not likely to cause adverse health consequences."